BioNexus Gene Lab
BGLC
$3.96
Share price
19.85%
Change (1 day)
366.09%
Change (1 year)
Categories
EPS for BioNexus Gene Lab (BGLC)
EPS in 2023 (TTM): -$0.06151
According to BioNexus Gene Lab's latest financial reports the company's current EPS (TTM) is -$0.06122. In 2022 the company made an earnings per share (EPS) of -$0.03226 a decrease over its 2021 EPS that were of $0.04887.
EPS history for BioNexus Gene Lab from 2019 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.06151 | 90.65% |
| 2022 | -$0.03226 | -166.02% |
| 2021 | $0.04887 | -74.82% |
| 2020 | $0.19 | -600.17% |
| 2019 | -$0.03880 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | -$2.94 | 4,699.33% | 🇺🇸 USA |